Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's Disease.

Ruggero BacchinMarco LiccariMauro CatalanLucia AntonuttiPaolo ManganottiMaria Chiara MalagutiBruno Giometto

Published in: Drugs - real world outcomes (2024)

This study confirms the good tolerability/safety profile of opicapone in a real-life setting and provides country-specific data for Italian patients with Parkinson's disease.

Keyphrases

open label
emergency department
randomized controlled trial
clinical trial
electronic health record
machine learning
double blind
placebo controlled